Why the study?
The study was conducted to observe the effect of RFCA in patients with PAF and explore risk factors for late recurrence of AF after a single RFCA session.
What is the long-term efficacy of radiofrequency catheter ablation in maintaining sinus rhythm, and what are the risk factors for late recurrence in patients with paroxysmal atrial fibrillation?
What is the long-term efficacy of radiofrequency catheter ablation in maintaining sinus rhythm, and what are the risk factors for late recurrence in patients with paroxysmal atrial fibrillation?
Radiofrequency catheter ablation provides durable maintenance of sinus rhythm in the majority of patients with paroxysmal atrial fibrillation over a 3-year follow-up, with left atrial diameter and other anatomical factors predicting late recurrence.
Supports long-term sinus rhythm maintenance after ablation in paroxysmal AF; leaves open need for randomized confirmation of predictors.
OBJECTIVE: This study was performed to observe the effect of radiofrequency catheter ablation (RFCA) in patients with paroxysmal atrial fibrillation (PAF) and to explore the risk factors for late recurrence of atrial fibrillation (LRAF) after a single RFCA session. METHODS: In this retrospective study, 243 patients with PAF underwent RFCA and were followed up regularly. RESULTS: At a median follow-up of 37 months after a single procedure, 60.5% of patients maintained sinus rhythm (SR), and at a median follow-up of 42 months after multiple procedures, 74.9% of patients maintained SR. The statistically significant risk factors for LRAF after a single RFCA session were the left atrial diameter (LAD), left inferior pulmonary vein superior-inferior diameter (LIPV SID), PV number variation, circumferential pulmonary vein isolation (CPVI) combined with additional ablation, and early recurrence of atrial fibrillation (ERAF). The best cut-off value for LAD was 35.5 mm. CONCLUSIONS: During a 3-year follow-up, about 70% of the patients with PAF maintained SR. LRAF after a single procedure was associated with the LAD, LIPV SID, PV number variation, CPVI combined with additional ablation, and ERAF.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: